Cure51
Paris, France
Cure51's proprietary data collection system, based on long-term partnerships, enables the creation of a single multimodal and multi-omics database of Outliers. Using its proprietary discovery platform powered by computational modeling, Cure51 aims to understand the biological mechanisms responsible for this exceptional survival by identifying and validating targets that can act on these interactions, leading to first-order treatments.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- www.cure51.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Cure51?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now